BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18470904)

  • 1. Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.
    Fan J; Peng Z; Zhou C; Qiu G; Tang H; Sun Y; Wang X; Li Q; Le X; Xie K
    Cancer; 2008 Jul; 113(2):266-75. PubMed ID: 18470904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis.
    Li D; Peng Z; Tang H; Wei P; Kong X; Yan D; Huang F; Li Q; Le X; Li Q; Xie K
    Clin Cancer Res; 2011 Jun; 17(11):3558-68. PubMed ID: 21531817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer.
    Su C; Zhao J; Hong X; Yang S; Jiang Y; Hou J
    Mol Med Rep; 2019 Nov; 20(5):4202-4214. PubMed ID: 31545476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
    Kita H; Hikichi Y; Hikami K; Tsuneyama K; Cui ZG; Osawa H; Ohnishi H; Mutoh H; Hoshino H; Bowlus CL; Yamamoto H; Sugano K
    J Gastroenterol; 2006 Nov; 41(11):1053-63. PubMed ID: 17160516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.
    Zhu JS; Guo H; Song MQ; Chen GQ; Sun Q; Zhang Q
    World J Gastroenterol; 2008 Oct; 14(38):5887-92. PubMed ID: 18855989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.
    Li JN; Zhao L; Wu J; Wu B; Yang H; Zhang HH; Qian JM
    J Dig Dis; 2012 Jan; 13(1):24-32. PubMed ID: 22188913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of IFITM3 in colorectal carcinoma and its clinical significance].
    Cui K; Wang H; Zai S; Feng Y
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):352-5. PubMed ID: 26463025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.
    Grade M; Hörmann P; Becker S; Hummon AB; Wangsa D; Varma S; Simon R; Liersch T; Becker H; Difilippantonio MJ; Ghadimi BM; Ried T
    Cancer Res; 2007 Jan; 67(1):41-56. PubMed ID: 17210682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genes involved in metastasis of colon cancer identified by integrated analysis.
    Zhou Y; Zang Y; Yang Y; Xiang J; Chen Z
    Cancer Med; 2019 May; 8(5):2338-2347. PubMed ID: 30884206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary strand microRNAs mediate acquisition of metastatic potential in colonic adenocarcinoma.
    Chen DT; Hernandez JM; Shibata D; McCarthy SM; Humphries LA; Clark W; Elahi A; Gruidl M; Coppola D; Yeatman T
    J Gastrointest Surg; 2012 May; 16(5):905-12; discussion 912-3. PubMed ID: 22362069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive potential molecular biomarkers in colon cancer.
    Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
    Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.
    Laurell H; Bouisson M; Berthelemy P; Rochaix P; Dejean S; Besse P; Susini C; Pradayrol L; Vaysse N; Buscail L
    World J Gastroenterol; 2006 Jun; 12(21):3344-51. PubMed ID: 16733850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu J; Liu F; Li X; Song X; Zhou L; Jie J
    Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.
    Sporn JC; Jung B
    Am J Pathol; 2012 Jun; 180(6):2516-26. PubMed ID: 22542848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer.
    Feng X; Zhang Z; Sun P; Song G; Wang L; Sun Z; Yuan N; Wang Q; Lun L
    Dis Markers; 2020; 2020():6439614. PubMed ID: 33294056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer.
    Liu GJ; Wang YJ; Yue M; Zhao LM; Guo YD; Liu YP; Yang HC; Liu F; Zhang X; Zhi LH; Zhao J; Sun YH; Wang GY
    Sci Rep; 2020 Jul; 10(1):11951. PubMed ID: 32686693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.